[go: up one dir, main page]

DE1035146B - Process for the preparation of chloractinomycins - Google Patents

Process for the preparation of chloractinomycins

Info

Publication number
DE1035146B
DE1035146B DEF20373A DEF0020373A DE1035146B DE 1035146 B DE1035146 B DE 1035146B DE F20373 A DEF20373 A DE F20373A DE F0020373 A DEF0020373 A DE F0020373A DE 1035146 B DE1035146 B DE 1035146B
Authority
DE
Germany
Prior art keywords
chloractinomycins
desaminoactinomycins
preparation
actinomycins
benzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEF20373A
Other languages
German (de)
Inventor
Dr Hans Brockmann
Dr Heinz Groene
Dipl-Chem Dr Gottfried Pampus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DEF20373A priority Critical patent/DE1035146B/en
Publication of DE1035146B publication Critical patent/DE1035146B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00Antibiotics
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50Isolated enzymes; Isolated proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Description

Verfahren zur Herstellung von Chloractinomycinen Die Actinomycine sind Chromopeptide, deren chromophore Gruppe nach Brockmann und Mitarbeitern (Angewandte Chemie, Bd. 68, 1956 S. 70, 71) die 3-Amino-1,8-dimethylphenoxazon-(2)-4,5-dicarbonsäure (auch >>Actinocina genannt, s. S. 69) ist. Durch Säurehydrolyse können die Actinomvcine unter den im deutschen Patent 954 251 beschriebenen Bedingungen in Desaminoactinomycine übergeführt werden, die sich von den Actinomycinen dadurch unterscheiden, daß die 3ständige Aminogruppe durch eine Oxygruppe ersetzt ist. Diese Desaminoactinomycine besitzen nicht mehr die Hemmwirkung gegen Mikroorganismen, die den Actinomycinen zu eigen ist.Process for making chloractinomycins The actinomycins are chromopeptides whose chromophoric group according to Brockmann and co-workers (Angewandte Chemie, Vol. 68, 1956 pp. 70, 71) the 3-amino-1,8-dimethylphenoxazon- (2) -4,5-dicarboxylic acid (also called >> Actinocina, see p. 69). The actinomvcine under the conditions described in German patent 954 251 in desaminoactinomycine be transferred, which differ from the actinomycins in that the 3-position amino group is replaced by an oxy group. These desaminoactinomycins no longer have the inhibitory effect against microorganisms, the actinomycins is own.

Es wurde nun gefunden, daß man zu neuen Derivaten des Actinomycins kommen kann, wenn man die in 3-Stellung am Phenoxazongerüst der Desaminoactinomycine befindliche Hydroxylgruppe durch ein Chloratom ersetzt. Es ist überraschend, daß die hierzu erforderliche Einwirkung von Thionylchlorid das übrige Molekül nicht zerstört, insbesondere, daß die zu Lactonringen geschlossenen Seitenketten nach der Umsetzung unverändert sind. Mit Ammoniak liefern die nach dem Verfahren herstellbaren Verbindungen die entsprechenden Actinomy cine (vgl. die Patentanmeldung F 20374 IVb/12p).It has now been found that new derivatives of actinomycin can be obtained can come when one has the 3-position on the phenoxazone skeleton of the desaminoactinomycins located hydroxyl group replaced by a chlorine atom. It's surprising that the action of thionyl chloride required for this does not affect the rest of the molecule destroyed, in particular that the side chains closed to form lactone rings implementation are unchanged. With ammonia deliver those which can be produced by the process Compounds the corresponding Actinomy cine (see. Patent application F 20374 IVb / 12p).

Die Umwandlung der Hydroxylgruppe in 3-Stellung am Phenoxazongerüst der Desaminoactinomycine erfolgt durch Behandeln mit Thionylchlorid. Ein Zusatz von Hilfsstoffen, die die Chlorierung erleichtern, wie Chloranil, ist empfehlenswert.The conversion of the hydroxyl group in the 3-position on the phenoxazone skeleton the desaminoactinomycins are made by treatment with thionyl chloride. An addition of auxiliaries that facilitate chlorination, such as chloranil, is recommended.

Die als Ausgangsstoffe verwendeten Desaminoactinomycine sind Chromopeptide, die sich von den entsprechenden als Actinomycine bezeichneten Stoffwechselprodukten der Actinomycoten durch Austausch einer Aminogruppe am Phenoxazongerüst gegen eine Hydroxylgruppe ableiten. Man kann von den reinen Verbindungen ausgehen, wie sie die Desaminoactinomycine Cl, C, C, 1o, h, X1 und X2 darstellen. Ebenso kann man auch Mischungen, z. B. die Desaminoactinomycine C, J oder F, verwenden.The desaminoactinomycins used as starting materials are chromopeptides, the metabolic products of the corresponding metabolites called actinomycins the actinomycotes by exchanging an amino group on the phenoxazone structure for a Derive hydroxyl group. One can start from the pure connections like them represent the desaminoactinomycins Cl, C, C, 10, h, X1 and X2. Likewise you can also mixtures, e.g. B. the desaminoactinomycins C, J or F, use.

Die neuen Verbindungen sind antibakteriell wirksam und sollen zur Herstellung von Heilmitteln dienen. Außerdem können sie dazu benutzt werden, um durch Hydrolyse der Aminogruppe unwirksam gewordene Actinomycine wieder in wirksame Verbindungen überzuführen.The new compounds are antibacterial and are intended to Serving manufacture of remedies. They can also be used to Actinomycins which have become ineffective through hydrolysis of the amino group are converted back into effective ones Transfer connections.

Beispiel Eine Lösung von 250 mg Desaminoactinomycin und 70 mg Chloranil in 50 ccm Benzol wird mit 5 ccm Thionylchlorid 20 Minuten zum Sieden erhitzt. Nach dem Abdampfen des Lösungsmittels im Vakuum löst man den Rückstand in Benzol, gibt die Lösung durch eine Säule von Aluminiumoxyd (Brockmann, Aktivitätsstufe II) und wäscht dieses mit reichlich Benzol. Das als rote Zone in der Säule verbleibende Chloractinomycin C wird mit Benzol, das 25 °!o Essigester enthält, ausgewaschen. Es hinterbleibt beim Verdampfen dieser Lösungsmittel eine amorphe rote Masse, die sich beim Umlösen aus Essigester in roten, trapezförmigen Kristallen abscheidet. Das erhaltene Chloractinomycin hat eine bestimmte Ultraviolettabsorptionskurve (vgl. Abb. 1) und Infrarotabsorptionskurve (vgl. Abb. 2) und einen bestimmten R,-Wert in zwei verschiedenen Lösungsmittelgemischen, seine spezifische Drehung ist [a] 'D' = -131° 1L15° (c = 0,10 in Aceton). Die Ausbeute beträgt 70 % der Theorie.EXAMPLE A solution of 250 mg of desaminoactinomycin and 70 mg of chloranil in 50 cc of benzene is heated to boiling with 5 cc of thionyl chloride for 20 minutes. After the solvent has evaporated off in vacuo, the residue is dissolved in benzene, the solution is passed through a column of aluminum oxide (Brockmann, activity level II) and this is washed with plenty of benzene. The chloractinomycin C remaining as a red zone in the column is washed out with benzene containing 25% ethyl acetate. When these solvents evaporate, an amorphous red mass is left behind, which is deposited in red, trapezoidal crystals when it is dissolved from ethyl acetate. The chloractinomycin obtained has a specific ultraviolet absorption curve (see Fig. 1) and infrared absorption curve (see Fig. 2) and a specific R, value in two different solvent mixtures, its specific rotation is [a] 'D' = -131 ° 1L15 ° (c = 0.10 in acetone). The yield is 70 % of theory.

Analyse des Chloractinomycins C Gefunden ................. Cl 2,5 °/o, N 11,19 °/o; berechnet ................ C12,750/0, N 11,7 °/o. Der R,-Wert ist das Verhältnis von R - Laufstrecke des Actinomycinderivates Laufstrecke des entsprechenden Actinomycins R, des Chloractinomycins C a) inButanol-n-Dibutyläther-10°/oigeswäßriges Natrium-m- kresotinat (1 : 1 : 2) ...... = 1,72; b) in Butylacetat-n-Dibutyläther-10°/aiges wäßriges Natrium-m-kresotinat (3: 1 : 2) .. = 0,83.Analysis of Chloractinomycin C Found ................. Cl 2.5%, N 11.19%; calculated ................ C12.750 / 0, N 11.7%. The R value is the ratio of R - running distance of the running distance of the corresponding Actinomycinderivates actinomycin R, the Chloractinomycins C a) inButanol-n-dibutyl-10 ° / oigeswäßriges sodium m- kresotinat (1: 1: 2) ... ... = 1.72; b) in butyl acetate n-dibutyl ether 10% aqueous sodium m-cresotinate (3: 1: 2) .. = 0.83.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von Chloractinomycinen, dadurch gekennzeichnet, daß man Desaminoactinomycine mit Thionylchlorid in der Wärme behandelt.PATENT CLAIM: Process for the production of chloractinomycins, characterized in that one desaminoactinomycins with thionyl chloride in the heat treated.
DEF20373A 1956-05-24 1956-05-24 Process for the preparation of chloractinomycins Pending DE1035146B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEF20373A DE1035146B (en) 1956-05-24 1956-05-24 Process for the preparation of chloractinomycins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF20373A DE1035146B (en) 1956-05-24 1956-05-24 Process for the preparation of chloractinomycins

Publications (1)

Publication Number Publication Date
DE1035146B true DE1035146B (en) 1958-07-31

Family

ID=7089653

Family Applications (1)

Application Number Title Priority Date Filing Date
DEF20373A Pending DE1035146B (en) 1956-05-24 1956-05-24 Process for the preparation of chloractinomycins

Country Status (1)

Country Link
DE (1) DE1035146B (en)

Similar Documents

Publication Publication Date Title
DE1035146B (en) Process for the preparation of chloractinomycins
DE2228660A1 (en) Process for the production of a little alpha monohydroxylamino or alpha, alpha dihydroxylaminoanthraquinone compounds
DE1795129C3 (en) Process for the preparation of alkali metal salts of α-aminobenzylpenicillin and its epimers
MATSUI et al. Synthesen und Konfiguracionsermittlung in der Rotenoid-Reihe. X. Totalsynthese des Dihydro-rotenons
DE1295563B (en) Process for the preparation of 5-phenyl-7-chloro-1, 2-dihydro-3H-1, 4-benzodiazepinone (2) -4-oxide
DE859311C (en) Process for the preparation of 1,3-dimethyl-4-amino-5-formylamino-2,6-dioxypyrimidine from 1,3-dimethyl-4-amino-5-nitroso-2,6-dioxypyrimidine
DE479016C (en) Process for the production of choline monoborate
DE376635C (en) Process for the preparation of ketobutyric acids
DE835596C (en) Process for working up the mother liquors resulting from the conversion of p-oxyalkylphenones into pinacone compounds
DE1768044C3 (en) S-amino-5-deoxy-D-glucose-i-sulfonic acid and process for its preparation
AT158271B (en) Process for the preparation of pregnene (4) dione (3.20).
AT226707B (en) Process for the preparation of new 11b-benzo- (a) -quinolizine derivatives
DE837241C (en) Process for separating mixtures of stereoisomeric 1-(p-oxyphenyl)-2-(ª-methyl-?-phenyl-propylamino)-propanole-(1)
AT219038B (en) Process for the preparation of new isoindoline derivatives
DE1768540C (en) Process for the preparation of gona 1,3,5 (10) -triene 17 ones
AT160652B (en) Process for the preparation of oxyketones of the cyclopentanopolyhydrophenanthrene series.
DE952634C (en) Process for the preparation of compounds of the pyridine series
DE748758C (en) Process for the preparation of disubstituted tetrazoles
DE2635401C3 (en) Process for the preparation of pure 4-aminoindane
DE872043C (en) Process for the production of reductic acid
AT241706B (en) Process for the production of 18, 20 lactones of the pregnan series
AT214080B (en) Process for the preparation of new steroid compounds substituted in the 4-position
AT220763B (en) Process for the preparation of 21-alkyl derivatives of 17β-hydroxy-17α-pregn-20-yne
DE836645C (en) Process for the preparation of N-p-chlorophenyl-N-isopropyl biguanide
DE954251C (en) Process for the production of breakdown products of actinomycins